SCHEMBL28036770

SCHEMBL28036770

COCOc1nc(N)c2ccccc2n1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DCPS Q96C86 1/20 0.49
CYP1A1 P04798 3/20 0.46
CYP1A2 P05177 3/20 0.46
CYP1B1 Q16678 3/20 0.46
APP P05067 4/20 0.45
RAB9A P51151 5/20 0.43
NPC1 O15118 4/20 0.43
PKM P14618 4/20 0.43
KMT2A Q03164 2/20 0.43
ABCB1 P08183 2/20 0.41
HTR3A P46098 1/20 0.41
HRH4 Q9H3N8 1/20 0.41
SMN1; SMN2 Q16637 4/20 0.41
NFKB1 P19838 2/20 0.41
NFKB2 Q00653 2/20 0.41
RELA Q04206 2/20 0.41
POLB P06746 1/20 0.41
PI4KA P42356 1/20 0.41
PI4K2B Q8TCG2 1/20 0.41
PI4K2A Q9BTU6 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3023761 0.86 TLR7 (0.50) DCPSCYP1A1CYP1A2CYP1B1APP
Hydrochloric Acid SCHEMBL3231113 0.84 TLR7 (0.49) DCPSCYP1A1CYP1A2CYP1B1APP
SCHEMBL14964747 0.83 KMT2A (0.55) DCPSCYP1A1CYP1A2CYP1B1APP
SCHEMBL148103 0.81 DCPS (0.57) DCPSCYP1A1CYP1A2CYP1B1APP
SCHEMBL30689003 0.81 TLR8 (0.51) DCPSCYP1A1CYP1A2CYP1B1APP
Hydrochloric Acid SCHEMBL6017885 0.80 CYP1A1 (0.58) DCPSCYP1A1CYP1A2CYP1B1APP
SCHEMBL2586754 0.79 TLR8 (0.52) DCPSCYP1A1CYP1A2CYP1B1RAB9A
SCHEMBL6380647 0.78 TLR7 (0.45) DCPSCYP1A1CYP1A2CYP1B1APP
SCHEMBL10972564 0.76 DCPS (0.47) DCPSCYP1A1CYP1A2CYP1B1APP
Hydrochloric Acid SCHEMBL6908984 0.76 NCF1 (0.59) DCPSCYP1A1CYP1A2CYP1B1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112915092-A Combinations of AKT inhibitor compounds and abiraterone and methods of use 基因泰克公司 2021-06-08 CN disclosed
CN-111643504-A Combinations of AKT inhibitor compounds and chemotherapeutic agents and methods of use 基因泰克公司 2020-09-11 CN disclosed
CN-101939006-B Phosphoinositide 3-kinase inhibitor compounds is combined and using method with chemotherapeutics GENENTECH, INC. (US) 2015-09-16 CN disclosed